releases: https://www.cotton.senate.gov/news/press-releases/cotton-tillis-statement-on-president-bidens-decision-to-support-the-trips-waiver
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.cotton.senate.gov/news/press-releases/cotton-tillis-statement-on-president-bidens-decision-to-support-the-trips-waiver | Cotton, Tillis Statement on President Biden’s Decision to Support the TRIPS Waiver | 2021-05-05 | 2021 | 2021-05 | Republican | Senate | AR | Tom Cotton | C001095 | www.cotton.senate.gov | cotton | https://www.cotton.senate.gov/news/press-releases | scraper | FOR IMMEDIATE RELEASE Contact: James Arnold or Mary Collins Atkinson (202) 224-2353 May 5, 2021 Cotton, Tillis Statement on President Biden’s Decision to Support the TRIPS Waiver Washington, D.C. — Today, Senators Tom Cotton (R-Arkansas) and Thom Tillis (R-North Carolina) issued the following joint statement after the Biden administration announced its support for the TRIPS waiver, which will authorize the sharing of United States COVID-19 intellectual property with other countries: “Today’s disastrous decision by President Biden will do little to end the COVID-19 pandemic and help developing nations, but it will hand over America’s medical technology to adversarial states like China and Russia. We support distributing vaccines to countries that need them, but not in a way that jeopardizes America's successful vaccine development. It’s astonishing that President Biden is now providing the Chinese Communist Party with access to America’s intellectual property, medical research, and innovation.” Background: In March, Senator Cotton sent a letter to President Biden urging his administration to oppose a proposal at the World Trade Organization that would strip American companies of their intellectual property rights for any innovation related to COVID-19. | 1 | 2026-03-30T01:40:41Z | 2026-04-06T19:49:40Z |